MARIE COR ALCOS: Open Payments
NPI 1932857638 · TEMPLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 18 payments from 8 companies in 2025. Trend: 2023 $106 · 2024 $1,015 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $192 |
| Alnylam Pharmaceuticals Inc. | 3 | $103 |
| Novartis Pharmaceuticals Corporation | 4 | $87 |
| CVRx, Inc. | 1 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Impulse Dynamics (USA) Inc. | 1 | $38 |
| Novo Nordisk Inc | 1 | $23 |
Products named: LOKELMA, LEQVIO, ONPATTRO, Barostim Neo System, AMVUTTRA, JARDIANCE, CAMZYOS, Optimizer.
Industry payments across TX — which companies pay providers there.
